Open access · CC-BY
via OpenAlex
Recycling senescent cell lipids for targeted senotherapy
Xiaoxiao Ji, Xinzi He, Honglu Cai, Peng Tang, Hao Zhou, Jiajie Wang, Yifan Wu, Jinfeng Zhou, Zhang Lin, Kaicheng Xu, Changjian Lin, Xiaoyong Wu, Kanbin Wang, Wangmi Liu, Gang Feng
Nature Communications · 2026 · ▲ 3 citations
Abstract
Senescent cells (SnCs) are increasingly recognized as key contributors to osteoarthritis, with conventional strategies centered on their elimination. However, senolytic approaches face mounting limitations, driving the need for refined interventions. Here, we exploit SnCs’ lipid metabolic signature to develop a senotherapeutic strategy. Given the universal lipid accumulation in SnCs and the dual role of lipids as both metabolic liabilities and essential lubricants, we engineer an injectable nanoliposuction hydrogel platform designed for “waste recycling”. This system removes excess lipids to mitigate senescence(definition)-associated secretory phenotype (SASP) propagation and incorporates the harvested lipids as a pivotal component of the biomimetic lubricating system, thereby alleviating mechanical allodynia and cartilage wear. This strategy circumvents potential side effects associated with direct SnCs clearance and repurposes these traditionally harmful cells as functional resources. Our findings establish a shift in the philosophy of senescence therapy, transitioning the focus from destructive ablation to spatially adaptive reallocation of metabolites. Ji, He, Cai, and colleagues report an engineered senescence therapy that exploits lipid metabolic features of senescent cells, repurposing excess lipids as functional resources to improve joint function, and thus alleviating osteoarthritis without eliminating the cells.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41467-026-70486-0
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Ji, X., He, X., Cai, H., Tang, P., Zhou, H., Wang, J., Wu, Y., Zhou, J., Lin, Z., Xu, K., Lin, C., Wu, X., Wang, K., Liu, W., Feng, G., Yan, S., Jiang, G., Qu, Z., & Qi, Y. (2026). Recycling senescent cell lipids for targeted senotherapy. <em>Nature Communications</em>. https://doi.org/10.1038/s41467-026-70486-0
Vancouver
Ji X, He X, Cai H, Tang P, Zhou H, Wang J, et al. Recycling senescent cell lipids for targeted senotherapy. Nature Communications. 2026. doi:10.1038/s41467-026-70486-0.
BibTeX
@article{xiaoxiao2026Recycl,
title = {Recycling senescent cell lipids for targeted senotherapy},
author = {Xiaoxiao Ji and Xinzi He and Honglu Cai and Peng Tang and Hao Zhou and Jiajie Wang and Yifan Wu and Jinfeng Zhou and Zhang Lin and Kaicheng Xu and Changjian Lin and Xiaoyong Wu and Kanbin Wang and Wangmi Liu and Gang Feng and Shigui Yan and Guangyao Jiang and Zihao Qu and Yiying Qi},
journal = {Nature Communications},
year = {2026},
doi = {10.1038/s41467-026-70486-0},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular Cancer 2025
Open access · CC-BY
The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy
Cancer Science 2024
Open access · CC-BY
Senescence and senolysis in cancer: The latest findings
Bone Research 2024
Open access · CC-BY
Cross-talk of inflammation and cellular senescence: a new insight into the occurrence and progression of osteoarthritis
Cancer Management and Research 2020
Open access · OA
The Dynamic Process and Its Dual Effects on Tumors of Therapy-Induced Senescence
Nature Reviews Drug Discovery 2024
Open access · CC-BY
Senescence as a therapeutic target in cancer and age-related diseases
MedComm 2024
Open access · CC-BY